ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Anacor Pharmaceuticals, Inc. 

1060 East Meadow Circle

Palo Alto  California  94303  U.S.A.
Phone: 650-739-0700 Fax: 650-739-0139


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Anacor Pharmaceuticals, Inc. (ANAC) Announces Third Quarter 2014 Financial Results Conference Call And Webcast 10/31/2014 9:13:30 AM
Anacor Pharmaceuticals, Inc. (ANAC) Announces Pricing Of Offering Of $75 Million Of 2.00% Convertible Senior Notes Due 2021 10/10/2014 8:10:45 AM
Anacor Pharmaceuticals, Inc. (ANAC) Announces Proposed Offering Of $70 Million Of Convertible Senior Notes Due 2021 10/9/2014 10:55:28 AM
Anacor Pharmaceuticals, Inc. (ANAC) Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States 9/23/2014 11:25:37 AM
Anacor Pharmaceuticals, Inc. (ANAC) Appoints Wendell Wierenga To Its Board Of Directors 9/12/2014 10:11:22 AM
Anacor Pharmaceuticals, Inc. (ANAC) To Present At Morgan Stanley Global Healthcare Conference 9/4/2014 12:32:02 PM
Anacor Pharmaceuticals, Inc. (ANAC) Reports Second Quarter 2014 Financial Results 8/8/2014 9:09:33 AM
Anacor Pharmaceuticals, Inc. (ANAC) To Present At Upcoming Investor Conferences 8/7/2014 11:00:30 AM
Anacor Pharmaceuticals, Inc. (ANAC) Announces Second Quarter 2014 Financial Results Conference Call And Webcast 8/4/2014 9:56:07 AM
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million 7/21/2014 8:07:24 AM
12345678910...